Results 271 to 280 of about 104,517 (284)
Some of the next articles are maybe not open access.
Current Treatment Options in Neurology, 1999
Diagnosis and management of giant cell (temporal) arteritis (GCA) should be performed by physicians who can accurately monitor the ophthalmologic, neurologic, and systemic sequelae of the disease as well as the numerous side effects of systemic corticosteroids, which are typically necessary for treatment.
Roger E. Turbin, Mark J. Kupersmith
openaire +3 more sources
Diagnosis and management of giant cell (temporal) arteritis (GCA) should be performed by physicians who can accurately monitor the ophthalmologic, neurologic, and systemic sequelae of the disease as well as the numerous side effects of systemic corticosteroids, which are typically necessary for treatment.
Roger E. Turbin, Mark J. Kupersmith
openaire +3 more sources
Journal of Clinical Neuroscience, 2009
Giant cell arteritis (GCA) is an immune-mediated vasculitis affecting individuals over 50 years of age. It is characterised by granulomatous inflammation that affects medium-sized and large arteries. The wide spectrum of clinical manifestations can be divided into those related to tissue ischemia from vascular lesions and those related to a systemic ...
Helen V Danesh-Meyer +2 more
openaire +3 more sources
Giant cell arteritis (GCA) is an immune-mediated vasculitis affecting individuals over 50 years of age. It is characterised by granulomatous inflammation that affects medium-sized and large arteries. The wide spectrum of clinical manifestations can be divided into those related to tissue ischemia from vascular lesions and those related to a systemic ...
Helen V Danesh-Meyer +2 more
openaire +3 more sources
Current Treatment Options in Neurology, 2004
Patients with a suspected diagnosis of giant cell arteritis (GCA) should be started on high-dose corticosteroid therapy without delay. A temporal artery biopsy should be performed after initiation of therapy to confirm the diagnosis. Patients with acute visual or neurologic symptoms present a neuro-ophthalmic emergency.
Laura J. Balcer, Jennifer K Hall
openaire +3 more sources
Patients with a suspected diagnosis of giant cell arteritis (GCA) should be started on high-dose corticosteroid therapy without delay. A temporal artery biopsy should be performed after initiation of therapy to confirm the diagnosis. Patients with acute visual or neurologic symptoms present a neuro-ophthalmic emergency.
Laura J. Balcer, Jennifer K Hall
openaire +3 more sources
Lupus, 1998
In many populations giant cell arteritis (GCA) is the most common form of vasculitis. Genetic markers, ethnic factors, and increasing age over 50 years appear to enhance susceptibility and an infection may trigger its onset. Recent investigations provide evidence that the vasculitic reaction is part of an immune response to an antigen residing in ...
openaire +3 more sources
In many populations giant cell arteritis (GCA) is the most common form of vasculitis. Genetic markers, ethnic factors, and increasing age over 50 years appear to enhance susceptibility and an infection may trigger its onset. Recent investigations provide evidence that the vasculitic reaction is part of an immune response to an antigen residing in ...
openaire +3 more sources
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Journal of the American Medical Association (JAMA), 2016IMPORTANCE Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are related inflammatory disorders occurring in persons aged 50 years and older. Diagnostic and therapeutic approaches are heterogeneous in clinical practice. OBJECTIVE To summarize
F. Buttgereit +3 more
semanticscholar +1 more source
Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell Arteritis
Journal of Rheumatology, 2019Objective. To identify characteristics and factors associated with relapse and glucocorticoid (GC) dependence in patients with giant cell arteritis (GCA). Methods.
A. Dumont +9 more
semanticscholar +1 more source
Annals of Internal Medicine, 1978
Excerpt Although Horton described temporal arteritis in 1932, the syndrome did not get much attention until the past decade.
openaire +3 more sources
Excerpt Although Horton described temporal arteritis in 1932, the syndrome did not get much attention until the past decade.
openaire +3 more sources
Current Treatment Options in Cardiovascular Medicine, 2000
Giant cell arteritis is a medium-vessel vasculitis that affects both men and women. Because the disease commonly presents with nonspecific complaints stemming from cranial arterial insufficiency, the challenge for the physician is recognizing the diagnosis.
openaire +3 more sources
Giant cell arteritis is a medium-vessel vasculitis that affects both men and women. Because the disease commonly presents with nonspecific complaints stemming from cranial arterial insufficiency, the challenge for the physician is recognizing the diagnosis.
openaire +3 more sources
Archives of Family Medicine, 1994
Giant cell arteritis is a form of vasculitis affecting medium- and large-size arteries, with a predilection for vessels arising from the aortic arch. The origins of giant cell arteritis are unknown. However, ethnic affinities are prominent, with the majority of cases involving white, elderly patients.
openaire +3 more sources
Giant cell arteritis is a form of vasculitis affecting medium- and large-size arteries, with a predilection for vessels arising from the aortic arch. The origins of giant cell arteritis are unknown. However, ethnic affinities are prominent, with the majority of cases involving white, elderly patients.
openaire +3 more sources
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica
Nature Reviews Rheumatology, 2020D. Camellino +3 more
semanticscholar +1 more source